COMMERCIALIZATION OF GRAPHICAL INTRAVENOUS DRUG DISPLAY

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: 1R43GM066615-01A2
Agency Tracking Number: GM066615
Amount: $97,160.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: PHS2005-2
Timeline
Solicitation Year: 2005
Award Year: 2005
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
925 East 900 South, Slc, UT, 84105
DUNS: N/A
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 NOAH SYROID
 (801) 671-9674
 NSYROID@MEDVIS.COM
Business Contact
Phone: (801) 755-2353
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): Applied Medical Visualizations has developed a real-time graphical display showing model-based predictions of drug pharmacology (pharmacokinetics and pharmacodynamics), intended for use by anesthesiologists in the operating room. The administration of intravenous drugs improves when anesthesiologists are able to visualize model-predicted concentrations, effects and interactions due to drug-drug synergism. Preliminary studies have shown significant promise for this technology; time to wake-up after surgery was reduced from 7.5 to 4.5 minutes. However, a clinical validation of the model's accuracy is necessary before developing a commercial product. Our plan is to: Task I: Develop a data collection system for intravenous drug administration in the operating room. Task II: Collect drug administration, vital signs, clinical signs, plasma drug concentrations and bispectral index (BIS) data for 28 patients. Task III: Implement data-parsing and simulation software to predict drug pharmacokjnetic (PK) effect-site concentrations and pharmacodynamic (PD) effects. Task IV: Use the results to refine the drug display's models and measure the accuracy with which the models predict clinical responses (e.g. loss and recovery of responsiveness, vital sign responses to surgical stimuli, EEC (BIS) changes). Phase II: We plan to incorporate additional drug models (premedicatipns, inhalation gases and neuromuscular agents) and evaluate the graphical PKPD display's utility in the operating room. If successfully implemented, the display technology could result in fewer hypertensive and hypotensive episodes, fewer adjuvant drug interventions, a lower incidence of patient movement, a lower incidence of the need for pharmacologic reversal of opioid effect to restore spontanebus ventilation, and more rapid wakeup at the end of surgery. In Phase III, the graphical display technology will be integrated with drug infusion pumps and patient physiologic monitors.

* Information listed above is at the time of submission. *

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government